AML enforcement is now the top regulatory risk for crypto firms, CertiK reports. Global AML fines exceeded $900 million in H1 2025, led by OKX and KuCoin. SEC crypto penalties dropped 97% from 2024 as ...

Fraud and anti-money laundering (AML) capabilities have long operated as distinct entities, but this division is increasingly misaligned with today’s complex financial crime. Fraud and AML teams ...

PARADIGM data suggest azacitidine plus venetoclax improves AML event-free survival vs 7+3 with less toxicity; survival looks similar. In an interview with Targeted Oncology, Richard Stone, MD, ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. One important aspect of improving survival ...

This manuscript provides a single-cell transcriptomic atlas for AML (222 samples comprising 748,679 cells) integrating data from multiple studies. They use this dataset to investigate t(8;21) AML, and ...

The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental. JITing, or “just-in-time” compilation, can make relatively slow ...

Fidelity National Financial’s (FNF) legal battle with the Financial Crimes Enforcement Network (FinCEN) may soon be over, that is, if the court takes the recommendations of Magistrate Judge Samuel ...

Credit: Getty Images AML highlights from ASH 2025 include results from the AAML1831, MyeChild01, BIG-1, and PALG-AML1/2016 studies. Acute myeloid leukemia (AML) research presented at the ASH Annual ...

The SEC has reinforced anti-money laundering requirements for financial institutions handling low-priced securities through omnibus accounts, emphasizing enhanced scrutiny of transactions that may ...

CLN-049 monotherapy demonstrates promising efficacy, including multiple complete responses and encouraging response durability, in a heavily pretreated all-comer population of patients with R/R AML 31 ...

(RTTNews) - Shares of SELLAS Life Sciences Group Inc. (SLS) are up nearly 7% at $1.86 in premarket trading, following promising clinical data from its ongoing Phase 2 study of SLS009 in ...